Apurano Pharmaceuticals successfully completed the realignment of its shareholder base including a private placement to secure its further expansion.
We initiated the transaction and advised Apurano Pharmaceuticals in its funding round.
Apurano Pharmaceuticals successfully completed the realignment of its shareholder base including a private placement to secure its further expansion.
We initiated the transaction and advised Apurano Pharmaceuticals in its funding round.
Dermazentrum sold a majority ownership stake in an Owners Buy-out to Halder.
We advised Dermazentrum and its founder.
Vitafy Brands and EVP Group have merged.
We acted as advisor to Vitafy Brands and its shareholders.
Dermapharm has acquired C3 – Cannabinoid Compound Company GmbH from Canopy Growth Corporation.
We acted as advisor to the buyer.